However, the development of pancreatic cancer is not solely dependent on KRAS mutations; other genes, such as TP53, CDKN2A, and SMAD4, also play crucial roles in tumorigenesis and metastasis, with mutations detected in a significant proportion of pancreatic cancer cases [12]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.